IMMUNE-MEDIATED PANCYTOPENIA

IMMUNE-MEDIATED PANCYTOPENIA was reported 49 times

IMMUNE-MEDIATED PANCYTOPENIA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Substance P/Neurokinin-1 Receptor Antagonist [EPC] 6 0.0007
1 Programmed Death Receptor-1 Blocking Antibody [EPC] 45 0.0005
2 Tetracycline-class Antibacterial [EPC] 1 0.0001
3 CTLA-4-directed Blocking Antibody [EPC] 4 0.0001
4 Microtubule Inhibitor [EPC] 11 0.0001
5 Platinum-based Drug [EPC] 18 0.0001
6 CD52-directed Cytolytic Antibody [EPC] 1 0.0001
7 Bile Acid [EPC] 1 0.0000
8 Xanthine Oxidase Inhibitor [EPC] 6 0.0000
9 Alkylating Drug [EPC] 8 0.0000
10 Fluoroquinolone Antibacterial [EPC] 3 0.0000
11 General Anesthetic [EPC] 1 0.0000
12 beta3-Adrenergic Agonist [EPC] 1 0.0000
13 Vitamin D [EPC] 6 0.0000
14 Vitamin B12 [EPC] 6 0.0000
15 HMG-CoA Reductase Inhibitor [EPC] 6 0.0000
16 Nitroimidazole Antimicrobial [EPC] 1 0.0000
17 Vitamin C [EPC] 6 0.0000
18 Leukocyte Growth Factor [EPC] 2 0.0000
19 Folate Analog Metabolic Inhibitor [EPC] 6 0.0000
20 Integrin Receptor Antagonist [EPC] 1 0.0000
21 Interleukin-6 Receptor Antagonist [EPC] 1 0.0000
22 Azole Antifungal [EPC] 1 0.0000
23 Vascular Endothelial Growth Factor Inhibitor [EPC] 1 0.0000
24 Corticosteroid [EPC] 6 0.0000
25 Factor Xa Inhibitor [EPC] 1 0.0000
26 Kinase Inhibitor [EPC] 2 0.0000
27 Dihydropyridine Calcium Channel Blocker [EPC] 1 0.0000
28 Loop Diuretic [EPC] 1 0.0000
29 Platelet Aggregation Inhibitor [EPC] 1 0.0000
30 Tumor Necrosis Factor Blocker [EPC] 1 0.0000
31 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000